Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
about
Treatment for primary hypothyroidism: current approaches and future possibilities2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of HypothyroidismThyroid Hormone Replacement in Patients Following Thyroidectomy for Thyroid CancerDIAGNOSIS OF ENDOCRINE DISEASE: How reliable are free thyroid and total T3 hormone assays?Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacementAdding carbimazole to levothyroxine increases triiodothyronine and improves outcome in patients with primary hypothyroidism: a preliminary study from EgyptTandem mass spectrometry as a novel tool for elucidating pituitary-thyroid relationships.Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancerThe pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients.Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patientsMetabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.3,3'-Diiodothyronine concentrations in hospitalized or thyroidectomized patients: results from a pilot study.Weight changes in euthyroid patients undergoing thyroidectomyFree thyroxine level in the high normal reference range prescribed for nonpregnant women may reduce the preterm delivery rate in multiparousAn Inverse Relationship Between Weight and Free Thyroxine During Early Gestation Among Women Treated for Hypothyroidism.Weight Changes in Patients with Differentiated Thyroid Carcinoma during Postoperative Long-Term Follow-up under Thyroid Stimulating Hormone Suppression.Defending plasma T3 is a biological priority.Effects of Levothyroxine Replacement or Suppressive Therapy on Energy Expenditure and Body Composition.Correlations of free thyroid hormones measured by tandem mass spectrometry and immunoassay with thyroid-stimulating hormone across 4 patient populationsLean body mass-based levothyroxine replacement in young athyrotic patients with differentiated carcinoma of thyroid.Cardiac Effects of Thyrotropin Oversuppression with Levothyroxine in Young Women with Differentiated Thyroid Cancer.Thyroid hormone replacement therapy: three 'simple' questions, complex answers.Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.Thyroid hormone replacement: current status and challenges.Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.Impact of overt and subclinical hypothyroidism on exercise tolerance: a systematic review.Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level.Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.Neither Baseline nor Changes in Serum Triiodothyronine during Levothyroxine/Liothyronine Combination Therapy Predict a Positive Response to This Treatment Modality in Hypothyroid Patients with Persistent Symptoms.Maturation in serum thyroid function parameters over childhood and puberty: results of a longitudinal study.Thyroxine replacement: a clinical endocrinologist's viewpoint.Risks and safety of combination therapy for hypothyroidism.The emergence of levothyroxine as a treatment for hypothyroidism.Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association.Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer.Severe TSH Elevation and Pituitary Enlargement After Changing Thyroid Replacement to Compounded T4/T3 Therapy.Is measurement of TT3 by immunoassay reliable at low concentrations? A comparison of the Roche Cobas 6000 vs. LC-MSMSCurrent evidence for the treatment of hypothyroidism with levothyroxine/levotriiodothyronine combination therapy versus levothyroxine monotherapy.Management of hypothyroidism with combination thyroxine (T4) and triiodothyronine (T3) hormone replacement in clinical practice: a review of suggested guidance.Assessment of thyroid function in intensive care unit patients by liquid chromatography tandem mass spectrometry methods.
P2860
Q22305857-9F671F22-BC1F-49A4-9723-BD1D8F0087B1Q22306402-48DB6BC3-AE7A-43D1-BB2D-F0FF0889C947Q26765098-8D47D545-0600-470B-8D09-BC9CC2968850Q28080139-EFCCA3AA-A860-493A-A89E-A8ED7896A9BFQ28649731-20AB224F-6798-4CBC-A679-A11F6FC02413Q33620324-3FE3E2D9-94B0-45A6-9BD1-E5AC670904F7Q33801438-F37749F6-C367-480B-98EE-0150342CF19CQ33889219-3EEC4C4B-3431-4743-A5B4-C17E4E542725Q33925748-D4F8987C-011B-4B15-A525-FA6D3D5FE647Q33988437-61F6A3BE-3F23-4A93-8981-48A26AA6C96FQ34210538-5297D6B8-0B1E-4728-BFDE-0117FBD5CEB2Q34289592-CFB7B8B9-15A7-4A01-B4F5-B5C2E6687126Q35590118-72CE0DDE-F51E-40BD-A832-BE5BF8FBA660Q35615123-6F2AFF28-8DF2-4688-A4D3-4FC155901824Q35942378-A8C2FA1E-6E04-44B1-B233-CB97CF72A9BFQ36127610-A33C4910-A849-41E4-AB15-05CB535484C3Q36424622-26D1E96D-C335-4EAB-BECE-2CFBEEED0EEBQ36683228-A9CD504D-2DA2-4CD8-A9E6-07E1DF1DAEF8Q36787933-CD318795-8294-4FB2-ACD9-697AC759E48CQ36930705-D6426233-BE91-49D9-B17D-4AC5ABF4BA06Q37072847-52B30153-F091-4E11-8A7F-B095C4E3B9A8Q37290881-8AFF5A24-AF61-400B-A142-2E6533AEC5F1Q37743076-57BCE157-F7B8-460E-BDCA-23974DA42218Q37901475-E596A249-19E4-4D96-B545-0E249A667564Q38178080-889F0125-0B7D-44D7-8DB3-91A5DA99657EQ38241623-2AC7E66A-31EA-40E0-860E-D539F91FAE4CQ38668982-954D90D7-5FB5-4967-B9AE-10CDD3ABA73CQ38716870-7B3B1D26-F8A2-476D-8CE3-B503FB154A44Q38739410-3A6AF01E-DB78-4374-AF3B-A4CFC5CFA396Q38804128-872FADD1-F9D7-498C-A824-8AE42A69F887Q38820336-ECBF8FF1-56CF-4659-B2ED-11DF544D9AFAQ38823533-EF88A283-1E4A-4C95-BCCC-7F8C51675E79Q39040887-60C5B70A-FEB3-4B72-9BF4-60C6CD9C1875Q39544905-8E17718F-A547-45B2-A4CA-C890413B156BQ39769201-B0219F9F-6A6E-4BD6-9E8D-54E5228C5C21Q42381208-DB883B4A-BAFD-406B-B0D7-CAC1E28158D0Q42382203-88A3FAD7-1B2C-41F1-9245-9DFCE03D3B17Q48142406-16D458BE-C97C-4BE1-90DC-FCBB8B9C84B7Q48155725-7DF8EB10-83E5-4420-B05B-509F2C2A8F99Q51301282-1F13764F-3CDC-40DB-974B-AA474EBA4DFA
P2860
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
@ast
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
@en
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
@nl
type
label
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
@ast
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
@en
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
@nl
prefLabel
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
@ast
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
@en
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
@nl
P2093
P356
P1476
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
@en
P2093
Bruce Davidson
Steven J Soldin
Supna Bhagat
P304
P356
10.1001/JAMA.299.7.769
P407
P577
2008-02-01T00:00:00Z